Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer

Figure 6

Immune landscape of ETV7 in various immune cells. (a)–(c) ESTIMATE algorithm immune, stromal, and estimate score. (d) Barplot showing the proportion of TICs in BLCA samples. Column names of plot were the sample’s ID. (e) Violin plot showed the ratio differentiation of 21 kinds of immune cells between BLCA samples with low or high ETV7 expression relative to the median of ETV7 expression level, and Wilcoxon rank sum was used for the significance test.

(a)

(b)

(c)

(d)

(e)